Recurrent Glioblastoma: What Is the Route?

Cancers (Basel) · 2023 · PMC10093407 · PMID 37046689

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Conventional systemic therapy with nitrosoureas and temozolomide rechallenge has limited efficacy, thus leading to an increasing trend toward precision medicine and targeted therapy for GBM.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.